Literature DB >> 14666008

Home surveillance program prevents interstage mortality after the Norwood procedure.

N S Ghanayem1, G M Hoffman, K A Mussatto, J R Cava, P C Frommelt, N A Rudd, M M Steltzer, S M Bevandic, S S Frisbee, R D B Jaquiss, S B Litwin, J S Tweddell.   

Abstract

OBJECTIVE: To determine whether early identification of physiologic variances associated with interstage death would reduce mortality, we developed a home surveillance program.
METHODS: Patients discharged before initiation of home surveillance (group A, n = 63) were compared with patients discharged with an infant scale and pulse oximeter (group B, n = 24). Parents maintained a daily log of weight and arterial oxygen saturation according to pulse oximetry and were instructed to contact their physician in case of an arterial oxygen saturation less than 70% according to pulse oximetry, an acute weight loss of more than 30 g in 24 hours, or failure to gain at least 20 g during a 3-day period.
RESULTS: Interstage mortality among infants surviving to discharge was 15.8% (n = 9/57) in group A and 0% (n = 0/24) in group B (P =.039). Surveillance criteria were breached for 13 of 24 group B patients: 12 patients with decreased arterial oxygen saturation according to pulse oximetry with or without poor weight gain and 1 patient with poor weight gain alone. These 13 patients underwent bidirectional superior cavopulmonary connection (stage 2 palliation) at an earlier age, 3.7 +/- 1.1 months of age versus 5.2 +/- 2.0 months for patients with an uncomplicated interstage course (P =.028). A growth curve was generated and showed reduced growth velocity between 4 and 5 months of age, with a plateau in growth beyond 5 months of age.
CONCLUSION: Daily home surveillance of arterial oxygen saturation according to pulse oximetry and weight selected patients at increased risk of interstage death, permitting timely intervention, primarily with early stage 2 palliation, and was associated with improved interstage survival. Diminished growth identified 4 to 5 months after the Norwood procedure brings into question the value of delaying stage 2 palliation beyond 5 months of age.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666008     DOI: 10.1016/s0022-5223(03)00071-0

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  53 in total

1.  Effects of health disparities on survival after neonatal heart surgery: why should racial, ethnic, gender, and socioeconomic status be included in the risk analysis?

Authors:  Joseph J Sistino; Charles Ellis
Journal:  J Extra Corpor Technol       Date:  2011-12

2.  Interventions after Norwood procedure: comparison of Sano and modified Blalock-Taussig shunt.

Authors:  Julia Fischbach; Nicodème Sinzobahamvya; Christoph Haun; Ehrenfried Schindler; Peter Zartner; Martin Schneider; Viktor Hraška; Boulos Asfour; Joachim Photiadis
Journal:  Pediatr Cardiol       Date:  2012-06-04       Impact factor: 1.655

3.  Risk factors for interstage death after the Norwood procedure.

Authors:  J M Simsic; S M Bradley; M R Stroud; A M Atz
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

4.  Digoxin Use in Infants with Single Ventricle Physiology: Secondary Analysis of the Pediatric Heart Network Infant Single Ventricle Trial Public Use Dataset.

Authors:  Dongngan T Truong; Shaji C Menon; Linda M Lambert; Phillip T Burch; Xiaoming Sheng; L LuAnn Minich; Richard V Williams
Journal:  Pediatr Cardiol       Date:  2018-05-24       Impact factor: 1.655

Review 5.  The intensive care of infants with hypoplastic left heart syndrome.

Authors:  U Theilen; L Shekerdemian
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

6.  Characteristics of Interstage Death After Discharge from Stage I Palliation.

Authors:  Humera Ahmed; Jeffrey B Anderson; Katherine E Bates; Shobha Natarajan; Nancy S Ghanayem; Carole M Lannon; David W Brown
Journal:  Pediatr Cardiol       Date:  2021-05-04       Impact factor: 1.655

7.  Clinical course and interstage monitoring after the Norwood and hybrid procedures for hypoplastic left heart syndrome.

Authors:  Walter Knirsch; Sonia Bertholdt; Gaby Stoffel; Brian Stiasny; Roland Weber; Hitendu Dave; Rene Prêtre; Michael von Rhein; Oliver Kretschmar
Journal:  Pediatr Cardiol       Date:  2014-01-18       Impact factor: 1.655

8.  Is Clinic Visit Frequency Associated with Weight Gain During the Interstage Period? A Report from the Joint Council on Congenital Heart Disease National Pediatric Cardiology Quality Improvement Collaborative (JCCHD-NPCQIC).

Authors:  David M Hurst; Matthew E Oster; Sherry Smith; Martha L Clabby
Journal:  Pediatr Cardiol       Date:  2015-04-29       Impact factor: 1.655

9.  Variation in feeding practices following the Norwood procedure.

Authors:  Linda M Lambert; Nancy A Pike; Barbara Medoff-Cooper; Victor Zak; Victoria L Pemberton; Lisa Young-Borkowski; Martha L Clabby; Kathryn N Nelson; Richard G Ohye; Bethany Trainor; Karen Uzark; Nancy Rudd; Louise Bannister; Rosalind Korsin; David S Cooper; Christian Pizarro; Sinai C Zyblewski; Bronwyn H Bartle; Richard V Williams
Journal:  J Pediatr       Date:  2013-11-06       Impact factor: 4.406

10.  Cause, timing, and location of death in the Single Ventricle Reconstruction trial.

Authors:  Richard G Ohye; Julie V Schonbeck; Pirooz Eghtesady; Peter C Laussen; Christian Pizarro; Peter Shrader; Deborah U Frank; Eric M Graham; Kevin D Hill; Jeffrey P Jacobs; Kirk R Kanter; Joel A Kirsh; Linda M Lambert; Alan B Lewis; Chitra Ravishankar; James S Tweddell; Ismee A Williams; Gail D Pearson
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-15       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.